New York, NY -- (SBWIRE) -- 12/31/2012 -- Growing Stock Report iniates a NASDAQ Morning Market Watch List and Investor Poll for the following stocks: LodgeNet Interactive Corporation (NASDAQ:LNET), ZaZa Energy Corporation (NASDAQ:ZAZA), American Learning Corporation (NASDAQ:ALRN) and Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)
LodgeNet Interactive Corporation (NASDAQ:LNET) As of This Writing Down (-28.75%)
LodgeNet Interactive Corporation (LNET) today announced that it has entered into a definitive agreement with a syndicate formed by an affiliate of Colony Capital (herein "Colony Syndicate"), a global investment firm with $38 billion in assets under management and a broad range of hospitality and media industry investments, pursuant to which the Colony Syndicate will provide $60 million of new capital to support a proposed recapitalization of the Company. In addition, the Company has received support from a steering committee of its lenders holding its debt for a multi-year extension of its existing $346 million secured credit facility.
Get Poll & LNET Consensus Report Here: http://www.growingstockreport.com/Survey.aspx?stock=LNET
ZaZa Energy Corporation (NASDAQ:ZAZA) As of This Writing Down (-5.09%)
Last Week, ZaZa Energy completed the sale of its French assets to a unit of Vermilion Energy for about $85.8 million.The exploration and development company agreed to sell the business to Vermilion, a Canadian company, in November.
Get Poll & ZAZA Consensus Report Here: http://www.growingstockreport.com/Survey.aspx?stock=ZAZA
American Learning Corporation (NASDAQ:ALRN) - As of This Writing Down (-13.24%)
American Learning Corporation, through subsidiaries, offers services to children with developmental delays and disabilities. The Company offers evaluation, speech practice, and autism services. American Learning serves children in hospitals, home-based early intervention, preschool programs, private therapy, public schools and charter schools.
Get Poll & ALRN Consensus Report Here: http://www.growingstockreport.com/Survey.aspx?stock=ALRN
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) As of This Writing Down (-3.16%)
Cyclacel Pharmaceuticals, Inc. a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, In mid December,announced that it has entered into a common stock purchase agreement (the Purchase Agreement) with Aspire Capital Fund, LLC (Aspire). Aspire has committed to purchase up to $20 million of Cyclacel's common stock from time to time as directed by Cyclacel over the next two years at prices based on the market price at the time of each sale.
Get Poll & CYCC Consensus Report Here: http://www.growingstockreport.com/Survey.aspx?stock=CYCC
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.GrowingStockReport.com
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.
Growing Stock Report
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)